Laurie A. Miller is SVP, Human Resources of HAEMONETICS CORP. Currently has a direct ownership of 17,807 shares of HAE, which is worth approximately $1.38 Million. The most recent transaction as insider was on Sep 17, 2024, when has been sold 238 shares (Common Stock) at a price of $76.54 per share, resulting in proceeds of $18,216. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.8K
0% 3M change
23.98% 12M change
Total Value Held $1.38 Million

Laurie A. Miller Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 17 2024
SELL
Payment of exercise price or tax liability
$18,216 $76.54 p/Share
238 Reduced 1.32%
17,807 Common Stock
May 28 2024
SELL
Payment of exercise price or tax liability
$74,477 $95.73 p/Share
778 Reduced 4.13%
18,045 Common Stock
May 28 2024
BUY
Grant, award, or other acquisition
-
2,650 Added 12.34%
18,823 Common Stock
May 17 2024
SELL
Payment of exercise price or tax liability
$7,275 $95.73 p/Share
76 Reduced 0.54%
14,084 Common Stock
May 17 2024
BUY
Grant, award, or other acquisition
-
2,089 Added 11.44%
16,173 Common Stock
May 16 2024
SELL
Payment of exercise price or tax liability
$22,088 $94.8 p/Share
233 Reduced 1.62%
14,160 Common Stock
May 15 2024
SELL
Payment of exercise price or tax liability
$22,482 $96.49 p/Share
233 Reduced 1.59%
14,393 Common Stock
Sep 15 2023
SELL
Payment of exercise price or tax liability
$18,832 $90.11 p/Share
209 Reduced 1.43%
14,363 Common Stock
Jun 02 2023
SELL
Payment of exercise price or tax liability
$16,794 $86.57 p/Share
194 Reduced 1.31%
14,572 Common Stock
May 18 2023
SELL
Payment of exercise price or tax liability
$7,500 $83.34 p/Share
90 Reduced 0.61%
14,766 Common Stock
May 16 2023
SELL
Payment of exercise price or tax liability
$20,964 $89.21 p/Share
235 Reduced 1.56%
14,856 Common Stock
May 15 2023
BUY
Grant, award, or other acquisition
-
2,102 Added 12.23%
15,091 Common Stock
May 12 2023
SELL
Payment of exercise price or tax liability
$2,821 $88.16 p/Share
32 Reduced 0.25%
12,989 Common Stock
Sep 19 2022
SELL
Open market or private sale
$16,165 $76.25 p/Share
212 Reduced 1.64%
12,697 Common Stock
Jul 05 2022
SELL
Open market or private sale
$2,780 $66.18 p/Share
42 Reduced 0.32%
12,909 Common Stock
Jun 13 2022
SELL
Open market or private sale
$1,878 $62.6 p/Share
30 Reduced 0.23%
12,951 Common Stock
Jun 02 2022
SELL
Open market or private sale
$12,413 $62.69 p/Share
198 Reduced 1.5%
12,981 Common Stock
May 19 2022
SELL
Open market or private sale
$5,378 $59.1 p/Share
91 Reduced 0.69%
13,179 Common Stock
May 16 2022
SELL
Open market or private sale
$1,739 $56.1 p/Share
31 Reduced 0.3%
10,232 Common Stock
May 16 2022
BUY
Grant, award, or other acquisition
-
3,038 Added 18.63%
13,270 Common Stock
Sep 17 2021
BUY
Grant, award, or other acquisition
-
2,848 Added 22.03%
10,081 Common Stock
LAM

Laurie A. Miller

SVP, Human Resources
Boston, MA

Track Institutional and Insider Activities on HAE

Follow HAEMONETICS CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HAE shares.

Notify only if

Insider Trading

Get notified when an Haemonetics Corp insider buys or sells HAE shares.

Notify only if

News

Receive news related to HAEMONETICS CORP

Track Activities on HAE